Australia's CSL stands by profit guidance due to strong demand for blood products [Reuters]
CSL LTD SP/ADR (CSLLY)
NASDAQ:AMEX Investor Relations:
csl.com/investors
Company Research
Source: Reuters
Australia's CSL stands by profit guidance due to strong demand for blood products (Reuters) - Australian plasma and vaccine specialist CSL Ltd said it was standing by profit guidance for the current business year due to strong demand for its products amid the coronavirus pandemic. It expects $2.11 billion to $2.17 billion in net profit attributable to shareholders for the year to end-June 2020, up from $1.92 billion a year earlier. Shares in CSL were 1.5% higher in late morning trade, giving the blood products giant a market capitalisation of A$143.6 billion ($89 billion). The Melbourne-based firm said that at present there is no interruption to its supply chain and that its facility in Wuhan, China has resumed operations. Plasma collections, however, are like likely to experience disruptions due to restrictions on people’s movements imposed by governments due to the pandemic, it added. “Whilst there are challenges to the logistics of plasma collection due to CVD 19, investors continu
Show less
Read more
Impact Snapshot
Event Time:
CSLLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSLLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSLLY alerts
High impacting CSL LTD SP/ADR news events
Weekly update
A roundup of the hottest topics
CSLLY
News
- Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons [Yahoo! Finance]Yahoo! Finance
- Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three SeasonsPR Newswire
- Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia Teens [Yahoo! Finance]Yahoo! Finance
- Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia TeensGlobeNewswire
- Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL" [Yahoo! Finance]Yahoo! Finance